Price T Rowe Associates Inc Enveric Biosciences, Inc. Transaction History

Price T Rowe Associates Inc

  • $816 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$8.8 - $16.2 $946,000 - $1.74 Million
-107,500 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$12.5 - $52.0 $392,500 - $1.63 Million
-31,400 Reduced 22.61%
107,500 $35,000
Q4 2021

Feb 14, 2022
BUY
$46.5 - $104.0 $3.99 Million - $8.92 Million
85,800 Added 161.58%
138,900 $129,000
Q3 2021

Nov 15, 2021
BUY
$80.5 - $175.0 $4.27 Million - $9.29 Million
53,100 New
53,100 $110,000

About Enveric Biosciences, Inc.

ENVB Quotes by TradingView
  • Ticker ENVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,078,270
  • Market Cap $1.29M
  • Description
  • Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for...
More about ENVB
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email